Methods for treating cancer using agents that inhibit Wnt16 signaling

Details for Australian Patent Application No. 2005271763 (hide)

Owner The Regents of the University of California

Inventors He, Biao; Jablons, David M.; Xu, Zhidong; You, Liang

Agent Pizzeys

Pub. Number AU-A-2005271763

PCT Pub. Number WO2006/017318

Priority 60/645,709 20.01.05 US; 60/586,564 09.07.04 US

Filing date 11 July 2005

Wipo publication date 16 February 2006

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/017318 Priority application(s): WO2006/017318

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005271767-Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)

2005271753-Packaging and method for solid dose administration of an electronic identification chip and medicaments